Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review
ABSTRACT: Background: Overactive bladder (OAB) is a common clinical condition for which current drug treatment comprises drugs blocking the cholinergic nerve supply, or augmenting the adrenergic nerve supply, to the detrusor muscle of the urinary bladder. Current treatments have drawbacks, including...
Saved in:
Main Authors: | Silvia Joseph, MBBS (Author), Steffi A. Maria, MD (Author), Jacob Peedicayil, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overactive bladder
by: Anna Zwierzyńska
Published: (2021) -
Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.
by: Elham Aziminekoo, et al.
Published: (2014) -
Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022) -
The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020) -
Fesoterodine for the treatment of urinary incontinence and overactive bladder
by: Pamela Ellsworth
Published: (2009)